REFERENCES
- Cabannillas F, Hagemeister FB, McLaughlin P, et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 1987; 5: 407–412.
- Velasquez WS, Cabannillas F, Salvador P, et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 1988; 71: 117–122.
- Wilson WH, Bryant G, Bates S, et al. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1573–1582.
- Frei E, Cannellos GP. Dose: a critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–594.
- Appelbaum FR, Herzig GP, Ziegler JL, et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85–95.
- Appelbaum FR, Deisseroth AB, Graw RG Jr, et al. Prolonged complete remission following high-dose chemother-apy of Burkitt's lymphoma in relapse. Cancer 1978; 41: 1059–1063.
- Philip T, Biron H, Hervb P, et al. Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis. Eur J Cancer Clin Oncol 1983; 19: 1371-1379.
- Armitage JO. Treatment of non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1023–1030.
- Philip T, Armitage JO, Spitzer G, et al. High-dose ther-apy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493–1498.
- De Kreuk AM, Ossenkoppele GJ, Meijer CJLM, et al. Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transpl 1996; 17: 963–971.
- Rapoport AP, Lifton R, Constine LS, et al. Auto trans-plantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factors. Bone marrow transplantation 1997; 19: 883–890.
- Takvorian T, Cannellos GP, Ritz J, et al. Prolonged dis-ease-free survival after autologous bone marrow transplanta-tion in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 1987; 316: 1499–1505.
- Bosly A, Coiffier B, Gisselbrecht C, et al. Bone marrow transplantation prolongs survival after relapse in aggressive lymphoma patients treated with the LNH-84 regimen. J Clin Oncol 1992; 10: 1615-1623.
- Caracciolo D, Gavarotti P, Aglietta M, et al. High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma. Bone Marrow Transpl 1993; 12: 621–625.
- Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540–1545.
- Phillips G, Herzig G, Lazarus H, et al. Cyclophosphamide, total body irradiation, and autologous bone marrow transplantation for refractory malignant lym-phoma. Blood 1981; 58: 175 abs.